UK markets close in 6 hours 3 minutes

BioMarin Pharmaceutical Inc. (BMRN)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
75.90-0.55 (-0.72%)
At close: 04:00PM EDT
76.25 +0.35 (+0.46%)
After hours: 07:33PM EDT
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Cash flows from operating activities
Net income
205,455
167,645
141,561
-64,080
854,029
-
Depreciation & amortisation
105,315
104,386
101,969
108,039
105,172
-
Deferred income taxes
-38,336
-44,981
-52,087
-15,608
-889,993
-
Stock-based compensation
211,653
207,099
196,308
197,263
189,711
-
Change in working capital
-225,283
-336,539
-96,383
66,034
-224,935
-
Accounts receivable
-55,025
-190,435
-82,033
65,574
-59,035
-
Inventory
-159,780
-157,058
-68,264
-35,060
-61,151
-
Accounts payable
41,533
68,853
59,018
15,689
-87,025
-
Other working capital
163,213
51,648
44,362
185,311
-52,154
-
Other non-cash items
4,133
3,823
3,778
9,543
20,014
-
Net cash provided by operating activities
280,162
159,259
175,902
304,536
85,365
-
Cash flows from investing activities
Investments in property, plant and equipment
-116,949
-107,611
-131,540
-119,225
-137,519
-
Purchases of investments
-769,797
-868,496
-611,809
-937,143
-538,372
-
Sales/maturities of investments
781,278
864,863
619,995
691,049
555,834
-
Other investing activities
-
-
103,325
-994
66,436
24,192
Net cash used for investing activities
-95,468
-111,244
-20,029
-366,313
-53,621
-
Cash flows from financing activities
Debt repayment
-1,314
-2,286
-2,605
-3,039
-381,909
-
Common stock repurchased
-
-
0
0
-50,000
0
Other financing activities
-74,845
-85,794
-85,378
-46,203
-44,638
-
Net cash used provided by (used for) financing activities
-20,778
-18,727
-18,650
-48
181,118
-
Net change in cash
166,922
30,596
137,255
-61,882
211,712
-
Cash at beginning of period
580,074
724,531
587,276
649,158
437,446
-
Cash at end of period
743,990
755,127
724,531
587,276
649,158
-
Free cash flow
Operating cash flow
280,162
159,259
175,902
304,536
85,365
-
Capital expenditure
-116,949
-107,611
-131,540
-119,225
-137,519
-
Free cash flow
163,213
51,648
44,362
185,311
-52,154
-